Rechercher | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Affichage: 2 résultats.

- Article de périodique
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study.
Pipe, Steven W Shima, Midori Lehle, Michaela Shapiro, Amy Chebon, Sammy Fukutake, Katsuyuki Key, Nigel S Portron, Agnès Schmitt, Christophe Podolak-Dawidziak, Maria Selak Bienz, Nives Hermans, Cédric[UCL] Campinha-Bacote, Avrita Kiialainen, Anna Peerlinck, Kathelijne Levy, Gallia G Jiménez-Yuste, Victor (2019) The Lancet. Haematology — Vol. 6, no.6, p. e295-e305 (2019)
- Article de périodique
Transcript profiles of dendritic cells of PLOSL patients link demyelinating CNS disorders with abnormalities in pathways of actin bundling and immune response
Kiialainen, Anna Veckman, Ville Saharinen, Juha Paloneva, Juha Gentile, Massimiliano Hakola, Panu Hemelsoet, Dimitri Ridha, Basil Kopra, Outi Julkunen, Ilkka Peltonen, Leena (2007) Journal of Molecular Medicine — Vol. 85, no. 9, p. 971-983 (2007)